Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis

Osteoarthritis and Cartilage

Volumn 10, Issue 9, 2002, Pages 707-713

  Vilim V ^a   Olejarova M ^a   Machacek S ^a   Gatterova J ^a   Kraus, V B ^b   Pavelka, K ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

COMP; Markers; Osteoarthritis; Serum

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 16 F12; MONOCLONAL ANTIBODY 17 C10; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; JOINT CAVITY; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYMPTOMATOLOGY;

EID: 0036714354     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2002.0819     Document Type: Article

References (33)

1. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage
2. Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes
3. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins
4. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen
5. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasis and multiple epiphyseal displasia affect binding of calcium and collagen I, II, and IX
6. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family
7. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
8. The pathogenesis of osteoarthritis
9. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases
10. An analysis of 14 molecular markers for monitoring osteoarthritis: Segregation of the markers into clusters and distinguishing osteoarthritis at baseline
11. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee
12. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint
13. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint
14. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study
15. Serum biologic markers as predictors of disease progression in osteoarthritis of the knee
16. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis
17. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids
18. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnston county osteoarthritis project
19. Radiological assessment of osteo-arthrosis
20. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee
21. Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests
22. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic therapy in patients with osteoarthritis of the hip or knee
23. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis
24. A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon®) as a structure modifying therapy in osteoarthritis of the hip and knee
25. Statistical quality control and routine data processing for radioimmunoassays and immuno-metric assays
26. COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage
27. Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells
28. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness
29. Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinese 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest
30. Recommended methodology for assessing the progression of osteoarthritis of the hip and knee joints
31. Accuracy and precision of joint space width measurements in standard and macroradiographs of osteoarthritic knees
32. Effect of alignment of the medial tibial plateau and x-ray beam on apparent progression of knee osteoarthritis in the standing anteroposterior radiograph
33. Reasons for apparent widening of medial joint space in conventional standing anteroposterior knee radiographs of patients with osteoarthritis